Literature DB >> 8757840

Purification and characterization of an extracellular secretogenic non-membrane-damaging cytotoxin produced by clinical strains of Vibrio cholerae non-O1.

P K Saha1, H Koley, G B Nair.   

Abstract

Some clinical strains of Vibrio cholerae non-O1 produce an extracellular factor that evokes a rapid and dramatic cytotoxic response which manifests as cell rounding of Chinese hamster ovary (CHO) and HeLa cells without accompanying membrane damage. This study was performed to establish the identity of the non-membrane-damaging cytotoxin (NMDCY), which was not inhibited by antitoxins against cholera toxin, heat-labile toxin of enterotoxigenic Escherichia coli, El Tor hemolysin, Shiga-like toxin I, and Shiga-like toxin II, indicating that NMDCY did not bear an apparent immunological relationship with the above toxins and hemolysin. Brain heart infusion broth and AKI medium supported the maximal production of NMDCY; culture supernatant of AKI medium was found to be free of hemolysin activity, whereas in brain heart infusion broth hemolysin was coproduced with NMDCY. Maximal production of NMDCY in AKI medium was observed at 37 degrees C under shaking conditions with the pH of the medium adjusted to 8.5. NMDCY was purified to homogeneity by a three-step purification procedure which increased the specific activity of the cytotoxin by 1.7 X 10(5)-fold. The denatured molecular weight of the purified toxin was 35,000, and the cytotoxin was heat labile and sensitive to trypsin. Purification of the cytotoxin revealed an enterotoxic activity as reflected by its ability to accumulate fluid in the rabbit ileal loop. Both the cytotoxic and enterotoxic activities of NMDCY could be inhibited or neutralized by antiserum raised against purified cytotoxin but not by preimmune serum. Immunodiffusion test between purified NMDCY and antiserum gave a single well-defined precipitin band which showed reactions of complete identity, while, in an immunoblot assay, a well-defined single band was observed in the 35-kDa region. Our results indicate that the cytotoxic and enterotoxic activities expressed by NMDCY appear to contribute to the pathogenesis of the disease associated with V. cholerae non-O1 strains which produce this cytotoxin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8757840      PMCID: PMC174194          DOI: 10.1128/iai.64.8.3101-3108.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

1.  Comparative studies of five heat-labile toxic products of Escherichia coli.

Authors:  J Konowalchuk; N Dickie; S Stavric; J I Speirs
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

2.  Extracellular proteins of Vibrio cholerae: nucleotide sequence of the structural gene (hlyA) for the haemolysin of the haemolytic El Tor strain 017 and characterization of the hlyA mutation in the non-haemolytic classical strain 569B.

Authors:  R A Alm; U H Stroeher; P A Manning
Journal:  Mol Microbiol       Date:  1988-07       Impact factor: 3.501

3.  Experimental non-O group 1 Vibrio cholerae gastroenteritis in humans.

Authors:  J G Morris; T Takeda; B D Tall; G A Losonsky; S K Bhattacharya; B D Forrest; B A Kay; M Nishibuchi
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

4.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Purification and chemical characterization of a cholera toxin-cross-reactive cytolytic enterotoxin produced by a human isolate of Aeromonas hydrophila.

Authors:  J M Rose; C W Houston; D H Coppenhaver; J D Dixon; A Kurosky
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

7.  Bioactivity and immunological characterization of a cholera toxin-cross-reactive cytolytic enterotoxin from Aeromonas hydrophila.

Authors:  J M Rose; C W Houston; A Kurosky
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

8.  Shigella dysenteriae 1-like cytotoxic enterotoxins produced by Salmonella strains.

Authors:  I Kétyi; S Pácsa; L Emödy; A Vertényi; B Kocsis; B Kuch
Journal:  Acta Microbiol Acad Sci Hung       Date:  1979

Review 9.  Infection by verocytotoxin-producing Escherichia coli.

Authors:  M A Karmali
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

10.  Virulence properties and enterotoxin production of Aeromonas strains isolated from fish.

Authors:  Y Santos; A E Toranzo; J L Barja; T P Nieto; T G Villa
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

View more
  10 in total

1.  Cytotoxic activity of coagulase-negative staphylococci in bovine mastitis.

Authors:  S Zhang; C W Maddox
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

2.  Enterotoxigenicity of mature 45-kilodalton and processed 35-kilodalton forms of hemagglutinin protease purified from a cholera toxin gene-negative Vibrio cholerae non-O1, non-O139 strain.

Authors:  A Ghosh; D R Saha; K M Hoque; M Asakuna; S Yamasaki; H Koley; S S Das; M K Chakrabarti; A Pal
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

3.  Production of monoclonal antibodies to the non-membrane-damaging cytotoxin (NMDCY) purified from Vibrio cholerae O26 and distribution of NMDCY among strains of Vibrio cholerae and other enteric bacteria determined by monoclonal-polyclonal sandwich enzyme-linked immunosorbent assay.

Authors:  P K Saha; G B Nair
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

4.  Molecular analysis of Vibrio cholerae O1, O139, non-O1, and non-O139 strains: clonal relationships between clinical and environmental isolates.

Authors:  D V Singh; M H Matte; G R Matte; S Jiang; F Sabeena; B N Shukla; S C Sanyal; A Huq; R R Colwell
Journal:  Appl Environ Microbiol       Date:  2001-02       Impact factor: 4.792

5.  Detection of RTX toxin gene in Vibrio cholerae by PCR.

Authors:  K H Chow; T K Ng; K Y Yuen; W C Yam
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

6.  Cell vacuolation, a manifestation of the El tor hemolysin of Vibrio cholerae.

Authors:  R Mitra; P Figueroa; A K Mukhopadhyay; T Shimada; Y Takeda; D E Berg; G B Nair
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

7.  Molecular analysis of non-O1, non-O139 Vibrio cholerae associated with an unusual upsurge in the incidence of cholera-like disease in Calcutta, India.

Authors:  C Sharma; M Thungapathra; A Ghosh; A K Mukhopadhyay; A Basu; R Mitra; I Basu; S K Bhattacharya; T Shimada; T Ramamurthy; T Takeda; S Yamasaki; Y Takeda; G B Nair
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

8.  Identification of a vibrio cholerae RTX toxin gene cluster that is tightly linked to the cholera toxin prophage.

Authors:  W Lin; K J Fullner; R Clayton; J A Sexton; M B Rogers; K E Calia; S B Calderwood; C Fraser; J J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-02       Impact factor: 11.205

9.  Putative virulence traits and pathogenicity of Vibrio cholerae Non-O1, Non-O139 isolates from surface waters in Kolkata, India.

Authors:  Prasanta K Bag; Poulami Bhowmik; Tapas K Hajra; T Ramamurthy; Pradipta Sarkar; Mrinmoyee Majumder; Goutam Chowdhury; Suresh C Das
Journal:  Appl Environ Microbiol       Date:  2008-07-18       Impact factor: 4.792

10.  Incidence, virulence factors, and clonality among clinical strains of non-O1, non-O139 Vibrio cholerae isolates from hospitalized diarrheal patients in Kolkata, India.

Authors:  S Chatterjee; K Ghosh; A Raychoudhuri; G Chowdhury; M K Bhattacharya; A K Mukhopadhyay; T Ramamurthy; S K Bhattacharya; Karl E Klose; R K Nandy
Journal:  J Clin Microbiol       Date:  2009-01-21       Impact factor: 5.948

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.